RIBZVAL-D combines Rabeprazole Sodium, a potent proton pump inhibitor (PPI), with
Domperidone, a prokinetic agent. This combination provides comprehensive relief from acid
reflux, heartburn, and gastric discomfort, while also addressing nausea and improving gastric
motility.

Key Benefits:
● Rabeprazole Sodium: Reduces stomach acid production, relieving heartburn and
promoting healing of gastric ulcers
● Domperidone: Enhances gastric motility, preventing nausea and vomiting commonly
associated with acid reflux medications
● Provides effective symptom relief from Gastroesophageal reflux disease (GERD)
● Helps manage gastric irritation and acid-related disorders
● Ideal for fast relief from heartburn and digestive discomfort

Indications:
● Gastroesophageal reflux disease (GERD)
● Peptic ulcers and gastric erosions
● Acid reflux and heartburn
● Nausea and vomiting associated with acid-reducing medications